<DOC>
	<DOCNO>NCT00004077</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Combining one drug may kill tumor cell . PURPOSE : Phase II trial study effectiveness combine paclitaxel , ifosfamide , cisplatin treat patient metastatic testicular cancer recur follow treatment .</brief_summary>
	<brief_title>Paclitaxel , Ifosfamide , Cisplatin Treating Patients With Metastatic Testicular Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Determine feasibility combine paclitaxel , ifosfamide , cisplatin induction patient metastatic nonseminomatous germ cell tumor testis first relapse follow first line treatment bleomycin , etoposide , cisplatin . - Determine response rate regimen patient OUTLINE : This multicenter study . Patients receive paclitaxel IV 3 hour ifosfamide IV cisplatin IV daily 5 day . Patients stable respond disease repeat treatment every 3 week 4 course absence disease progression unacceptable toxicity . PROJECTED ACCRUAL : A minimum 25 patient accrue study .</detailed_description>
	<mesh_term>Neoplasms , Germ Cell Embryonal</mesh_term>
	<mesh_term>Testicular Neoplasms</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Isophosphamide mustard</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Ifosfamide</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Metastatic nonseminomatous germ cell tumor testis In first relapse follow first line treatment bleomycin , etoposide , cisplatin Biopsy proven germ cell tumor OR Rising tumor marker ( alpha fetoprotein and/or human chorionic gonadotropin ) No brain metastases PATIENT CHARACTERISTICS : Age : 16 64 Performance status : 02 Life expectancy : Not specify Hematopoietic : Not specify Hepatic : Not specify Renal : Glomerular filtration rate great 50 mL/min Other : No prior malignancy except curatively treat nonmelanomatous skin cancer superficial bladder cancer PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : See Disease Characteristics Endocrine therapy : Not specify Radiotherapy : Not specify Surgery : Not specify Other : No prior experimental drug</criteria>
	<gender>Male</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>January 2001</verification_date>
	<keyword>stage III malignant testicular germ cell tumor</keyword>
	<keyword>recurrent malignant testicular germ cell tumor</keyword>
	<keyword>testicular embryonal carcinoma</keyword>
	<keyword>testicular choriocarcinoma</keyword>
	<keyword>testicular teratoma</keyword>
	<keyword>testicular yolk sac tumor</keyword>
	<keyword>testicular embryonal carcinoma teratoma</keyword>
	<keyword>testicular embryonal carcinoma yolk sac tumor</keyword>
	<keyword>testicular yolk sac tumor teratoma</keyword>
	<keyword>testicular choriocarcinoma yolk sac tumor</keyword>
	<keyword>testicular choriocarcinoma embryonal carcinoma</keyword>
	<keyword>testicular choriocarcinoma teratoma</keyword>
</DOC>